Protocol No.: AMAG-FER-CKD-354

A Phase 3, Randomized, Open-Label, Multicenter Study to Evaluate the Safety (Compared to Iron Sucrose), Efficacy and Pharmacokinetics of Ferumoxytol for the Treatment of Iron Deficiency Anemia (IDA) in Pediatric Subjects with Chronic Kidney Disease (CKD)
Principal Investigator
Grossman, Oulimata
Phase
III
Age Group
Children
Applicable Disease Sites
Other Conditions/Diseases
Pediatrics
Participating Institution
Health Sciences Center
Contact
Robin Hoffer
Phone: +1 724-972-9170

View on ClinicalTrials.gov